Ketamine-based Sedation Use in Mechanically Ventilated Critically Ill Patients with COVID-19: A Multicenter Cohort Study

Ketamine-based Sedation Use in Mechanically Ventilated Critically Ill Patients with COVID-19: A Multicenter Cohort Study

Backgrounds: Ketamine possesses analgesia, anti-inflammation, anticonvulsant, and neuroprotection properties. However, the evidence that supports its use in mechanically ventilated critically ill patients with COVID-19 is insufficient. The study's goal was to assess ketamine's effectivenes...

Full description

Bibliographic Details
Main Authors: Ohoud Aljuhani, Khalid Al Sulaiman, Ghazwa B. Korayem, Ali F. Altebainawi, Abdulrahman Alshaya, Majed Nahari, Khuzama Alsamnan, Munirah A. Alkathiri, Bodoor S. Al-Dosari, Abeer A. Alenazi, Samiah Alsohimi, Lina I. Alnajjar, Mashael Alfaifi, Nora AlQussair, Reem M. Alanazi, Munirah F. Alhmoud, Nadin L. Alanazi, Hadeel Alkofide, Aljawharah M. Alenezi, Ramesh Vishwakarma
Format: Article
Language:English
Published: Elsevier 2024-05-01
Series:Saudi Pharmaceutical Journal
Subjects:
COVID-19
Ketamine
Oxygenation parameter
PaO2/FiO2 ratio
Length of Stay
Critically ill
Online Access:http://www.sciencedirect.com/science/article/pii/S1319016424001117

Internet

http://www.sciencedirect.com/science/article/pii/S1319016424001117

Similar Items